Skip to main content
Livermore
Livermore
ZHEN

Aviva PLC

SEC CIK
0001140022
Latest filing
Aug 13, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Aviva PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of BMRN by Aviva PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−62,431−100.0%Sold outHolders
Q3 202562,431$3.38M<0.1%+1,352+2.2%AddedHolders
Q2 202561,079$3.36M<0.1%+54,069+771.3%AddedHolders
Q1 20257,010$495.5K<0.1%−102−1.4%ReducedHolders
Q4 20247,112$467.5K<0.1%00.0%UnchangedHolders
Q3 20247,112$499.9K<0.1%−5,509−43.6%ReducedHolders
Q2 202412,621$1.04M<0.1%+5,452+76.0%AddedHolders
Q1 20247,169$626.1K<0.1%+181+2.6%AddedHolders
Q4 20236,988$673.8K<0.1%−33−0.5%ReducedHolders
Q3 20237,021$621.2K<0.1%−19,779−73.8%ReducedHolders
Q2 202326,800$2.32M<0.1%+17,506+188.4%AddedHolders
Q1 20239,294$904.0K<0.1%−55,771−85.7%ReducedHolders
Q4 202265,065$6.73M<0.1%+38,415+144.1%AddedHolders
Q3 202226,650$2.26M<0.1%−8,200−23.5%ReducedHolders
Q2 202234,850$2.89M<0.1%−1,183−3.3%ReducedHolders
Q1 202236,033$2.78M<0.1%−18,491−33.9%ReducedHolders
Q4 202154,524$4.82M<0.1%−1,309−2.3%ReducedHolders
Q3 202155,833$4.32M<0.1%−2,774−4.7%ReducedHolders
Q2 202158,607$4.89M<0.1%−2,375−3.9%ReducedHolders
Q1 202160,982$4.61M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.